News coverage about CME Group (NASDAQ:CME) has trended somewhat positive on Monday, Accern Sentiment reports. The research group ranks the sentiment of press coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. CME Group earned a daily sentiment score of 0.19 on Accern’s scale. Accern also gave media headlines about the financial services provider an impact score of 45.7313328445932 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

These are some of the media headlines that may have impacted Accern Sentiment’s scoring:

CME Group (NASDAQ CME) opened at 134.17 on Monday. CME Group has a 52 week low of $98.95 and a 52 week high of $134.36. The firm has a market capitalization of $45.61 billion, a price-to-earnings ratio of 27.39 and a beta of 0.72. The firm has a 50-day moving average price of $126.73 and a 200 day moving average price of $122.14.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Tuesday, August 1st. The financial services provider reported $1.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.20 by $0.03. CME Group had a return on equity of 7.61% and a net margin of 46.05%. The business had revenue of $925.00 million for the quarter, compared to analyst estimates of $931.05 million. During the same period last year, the company earned $1.14 EPS. CME Group’s revenue for the quarter was up 2.1% compared to the same quarter last year. On average, equities research analysts forecast that CME Group will post $4.82 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, September 25th. Stockholders of record on Friday, September 8th will be given a $0.66 dividend. The ex-dividend date is Thursday, September 7th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 1.97%. CME Group’s dividend payout ratio is currently 53.99%.

Several analysts have recently weighed in on CME shares. Barclays PLC began coverage on CME Group in a report on Friday, September 8th. They set an “overweight” rating and a $139.00 price target on the stock. BidaskClub cut CME Group from a “buy” rating to a “hold” rating in a report on Friday, September 1st. UBS AG reiterated a “buy” rating and issued a $135.00 target price (up from $134.00) on shares of CME Group in a report on Wednesday, September 6th. Zacks Investment Research cut CME Group from a “hold” rating to a “sell” rating in a report on Tuesday, July 11th. Finally, Deutsche Bank AG reduced their target price on CME Group from $139.00 to $136.00 and set a “buy” rating on the stock in a report on Tuesday, July 4th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and seven have given a buy rating to the company’s stock. CME Group has an average rating of “Buy” and an average target price of $133.22.

TRADEMARK VIOLATION WARNING: This piece of content was originally reported by Daily Political and is the property of of Daily Political. If you are reading this piece of content on another website, it was copied illegally and republished in violation of United States and international copyright & trademark law. The original version of this piece of content can be read at

In other news, Director Martin J. Gepsman sold 200 shares of CME Group stock in a transaction that occurred on Wednesday, August 9th. The stock was sold at an average price of $126.14, for a total value of $25,228.00. Following the sale, the director now directly owns 43,311 shares in the company, valued at approximately $5,463,249.54. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Chairman Terrence A. Duffy sold 21,815 shares of CME Group stock in a transaction that occurred on Wednesday, August 2nd. The stock was sold at an average price of $123.89, for a total value of $2,702,660.35. Following the completion of the sale, the chairman now owns 110,711 shares in the company, valued at $13,715,985.79. The disclosure for this sale can be found here. Over the last quarter, insiders sold 48,244 shares of company stock worth $6,021,890. Corporate insiders own 0.57% of the company’s stock.

About CME Group

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Insider Buying and Selling by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with's FREE daily email newsletter.